Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» M&A
M&A
Genmab leans into hot ADC space with $1.8B ProfoundBio acquisition
BioSpace
Wed, 04/3/24 - 11:38 am
Genmab
M&A
ProfoundBio
antibody-drug conjugate
Fierce Biotech's Quarterly IPO and M&A Roundup: Q1'24
Fierce Biotech
Wed, 04/3/24 - 11:36 am
biotech
M&A
IPOs
CG Oncology
Kyverna Therapeutics
Contineum Therapeutics
Boundless Bio
CymaBay Therapeutics
Gilead Sciences
MorphoSys
Novartis
Fusion Pharmaceuticals
AstraZeneca
Ambryx
JNJ
Inhibrix
Aventis
Novo’s $1.1B Cardior buy continues expansion into heart disease
BioSpace
Mon, 03/25/24 - 11:39 am
Novo Nordisk
Cardior Pharmaceuticals
M&A
heart disease
AbbVie to bolster immunity illness drug pipeline with Landos buy
Yahoo/Reuters
Mon, 03/25/24 - 11:39 am
AbbVie
Landos Biopharma
immune disorders
M&A
A year after the acquisition of Bellus Health, GSK planning to let go of most former Bellus employees
LinkedIn
Fri, 03/22/24 - 10:50 am
GSK
Bellus Health
M&A
layoffs
EU adviser says Illumina merger was not problematic
Stat
Fri, 03/22/24 - 09:33 am
Illumina
Grail
M&A
Europe
Elevance to buy Kroger’s specialty pharmacy
BioPharma Dive
Wed, 03/20/24 - 11:42 am
Elevance Health
PBMs
Kroger
specialty pharmacies
M&A
AstraZeneca scoops up Fusion Pharmaceuticals in $2.4B radiopharma deal
Medical Marketing and Media
Tue, 03/19/24 - 11:58 am
AstraZeneca
Fusion Pharmaceuticals
M&A
radiopharmaceuticals
Eliem cuts in on Tango, proposing acquisition after strategic review
Fierce Biotech
Tue, 03/19/24 - 11:51 am
Eliem Therapeutics
Tango Therapeutics
M&A
oncology
After Kyowa Kirin buyout, Orchard scores FDA approval for first MLD gene therapy in the US
Fierce Pharma
Mon, 03/18/24 - 05:16 pm
Orchard Therapeutics
Kyowa Kirin
M&A
Lenmeldy
FDA
metachromatic leukodystrophy
BMS, AstraZeneca, Novartis Add to 2024 M&A Upswing
BioSpace
Mon, 03/18/24 - 11:10 am
M&A
Bristol Myers Squibb
Novartis
AstraZeneca
Novo Nordisk
Pfizer
Should Pfizer Acquire Viking Therapeutics to Take on Eli Lilly and Novo Nordisk in the Obesity Drug Market?
Motley Fool
Fri, 03/15/24 - 11:13 am
Pfizer
obesity
M&A
Viking Therapeutics
AstraZeneca boosts rare disease portfolio with $1.05B Amolyt acquisition
BioSpace
Thu, 03/14/24 - 11:38 am
AstraZeneca
M&A
Amolyt Pharma
eneboparatide
hypoparathyroidism
COVID vaccine giants Moderna and Pfizer employ divergent tactics for the next chapter
Pharma Voice
Mon, 03/11/24 - 11:43 am
Moderna Therapeutics
Pfizer
vaccines
COVID-19
M&A
cancer
BiomX acquires fellow bacteria-killing virus company Adaptive Phage to accelerate phase 2 plans
Fierce Biotech
Wed, 03/6/24 - 11:26 am
BiomX
Adaptive Phage Therapeutics
M&A
cystic fibrosis
Ginkgo adds gene editing tools in buyout of Feng Zhang-founded startup
BioPharma Dive
Wed, 02/28/24 - 11:09 am
Ginkgo Bioworks
M&A
Proof Diagnostics
gene editing
Feng Zhang
Amgen details rare disease ambitions following $28B Horizon acquisition
Medical Marketing and Media
Sun, 02/25/24 - 09:04 pm
Amgen
Horizon Therapeutics
rare disease
M&A
AbbVie’s Cerevel deal hits an uncommon roadblock
BioPharma Dive
Wed, 02/21/24 - 11:10 am
AbbVie
Cerevel Therapeutics
M&A
FTC
antitrust
Novo Nordisk and Catalent deal: net positive or negative for industry?
Biopharma Reporter
Tue, 02/20/24 - 11:06 am
Novo Nordisk
Catalent
M&A
Wegovy
Ozempic
GSK completes acquisition of Aiolos Bio for up to $1.4 bln
Reuters
Thu, 02/15/24 - 11:19 am
GSK
Aiolos Bio
M&A
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »